CHAPTER MENU
| Background Information of Clinical Importance, 366 Anatomy and Physiology, 366 Diagnostic Methods, 367 Diagnosis of Cardiovascular Disease by Presenting Sign, 370 Sudden Death, 370 Abnormal Heart Sounds, 373 Arrhythmias, 373 Congestive Heart Failure, 374 | Subclinical Cardiovascular Conditions, 374 Specific Diseases of the Cardiovascular System, 374 Heartwater, 374 Schistosomosis, 378 References, 382 |
The occurrence of clinically recognized cardiovascular disease in goats is very low.
As a result, goats historically have been the least studied of the domestic species regarding normal cardiovascular function and pathophysiology. Over time, however, goats, which are relatively easy to handle and have a body and heart size comparable to human beings, have received more attention as a suitable animal model for the study of human cardiovascular disease and its management. In particular, goats have been used in studies of the effect of cardiac denervation on cardiorespiratory responses to exercise (Brice et al. 1991), pathophysiology and treatment of atrial fibrillation (Neuberger et al. 2006), the relation of chronic left atrial overload to persistent atrial fibrillation (Remes et al. 2008), chronic heart failure (Tessier et al. 2003), the development of skeletal muscle ventricles (Guldner et al. 2002), the development and testing of artificial heart valves (Bjork and Kaminsky 1992), the use of total artificial hearts, including one goat outfitted with a paracorporeal total artificial heart that survived for 532 days (Abe et al. 2007), and ischemic cardiomyopathy (Leroux et al. 2020).
Source:
Smith Mary C., Sherman David M.. Goat Medicine. 3rd edition. — Wiley-Blackwell,2023. — 976 p.. 2023
More on the topic CHAPTER MENU:
-
Veterinarian -